Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Similares en SciELO
Compartir
Revista de Enfermagem Referência
versión impresa ISSN 0874-0283versión On-line ISSN 2182-2883
Resumen
FERREIRA, Anabela Martins y MAGALHAES, Carlos Pires. Medication adherence in chronic kidney disease patients in haemodialysis programme. Rev. Enf. Ref. [online]. 2023, vol.serVI, n.2, e22039. Epub 01-Sep-2023. ISSN 0874-0283. https://doi.org/10.12707/rvi22039.
Background:
The person with chronic kidney disease (CKD) on hemodialysis has a complex drug therapy regimen to follow, both in the control of the symptoms caused by the disease and in the control of comorbidities.
Objective:
To assess the level of adherence to the drug treatment in CKD patients on a hemodialysis program.
Methodology:
Quantitative, descriptive-correlational and cross-sectional study, based on the application of the Measure of Treatment Adherence scale (MTA), to a sample of 101 people with CKD, undergoing hemodialysis.
Results:
The sample had a mean score of adherence to the drug treatment regimen of 5.32 ± 0.47, with a maximum value of 6. The dichotomous pattern of the scale, based on the median, classifies 82.18% of the sample (n = 83) as adherent and 17.82% (n = 18) as non-adherent. A statistically significant relationship of adherence was found as a function of some clinical variables: number of pathologies and daily medication.
Conclusion:
The percentage of non-adherents to the drug therapy regimen calls for improvement actions and highlights the importance of continuous assessment of adherence levels.
Palabras clave : end stage renal disease; hemodialysis; medication adherence.